 FREEHOLD, N.J., March 29, 2021 GLOBE NEWSWIRE -- Avalon GloboCare Corp. NASDAQ: AVCO Avalon or The Company, a clinical-stage global developer of cell-based technologies and therapeutics, today announces entering into a collaboration agreement with the University of Pittsburgh Medical Center UPMC Hillman Cancer Center to advance the clinical development and production of Avalons next-generation, chimeric antigen receptor CAR therapies using FLASH CARTM technology. 